Chunghwa Chemical Synthesis & Biotech Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Chunghwa Chemical Synthesis & Biotech.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	36.4%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	Low
Last updated	28 Mar 2024

Recent future growth updates

Recent updates

Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04

A Look At The Intrinsic Value Of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Apr 01

Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TPE:1762) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 04

What To Know Before Buying Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762) For Its Dividend

Jan 28

Should You Rely On Chunghwa Chemical Synthesis & Biotech's (TPE:1762) Earnings Growth?

Jan 02

The Chunghwa Chemical Synthesis & Biotech (TPE:1762) Share Price Is Up 131% And Shareholders Are Boasting About It

Dec 06

Earnings and Revenue Growth Forecasts

TWSE:1762 - Analysts future estimates and past financials data (TWD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2024	1,730	207	202	452	1
12/31/2023	2,086	265	-518	-66	N/A
9/30/2023	2,173	290	-468	69	N/A
6/30/2023	2,300	399	-96	435	N/A
3/31/2023	2,353	517	-16	578	N/A
12/31/2022	2,117	466	358	734	N/A
9/30/2022	2,082	488	309	685	N/A
6/30/2022	2,122	452	136	541	N/A
3/31/2022	2,043	430	-222	257	N/A
12/31/2021	1,935	401	-186	219	N/A
9/30/2021	1,987	408	-222	86	N/A
6/30/2021	1,766	358	-198	107	N/A
3/31/2021	1,658	602	30	230	N/A
12/31/2020	1,544	532	-55	138	N/A
9/30/2020	1,260	470	28	212	N/A
6/30/2020	1,193	461	118	267	N/A
3/31/2020	1,120	104	150	261	N/A
12/31/2019	1,157	117	153	268	N/A
9/30/2019	1,113	76	108	231	N/A
6/30/2019	1,074	270	87	199	N/A
3/31/2019	1,087	272	27	140	N/A
12/31/2018	1,019	234	141	235	N/A
9/30/2018	1,131	286	-267	318	N/A
6/30/2018	1,313	129	-441	349	N/A
3/31/2018	1,172	101	-544	260	N/A
12/31/2017	1,168	86	-646	159	N/A
9/30/2017	1,126	67	N/A	160	N/A
6/30/2017	1,100	19	N/A	141	N/A
3/31/2017	1,204	31	N/A	224	N/A
12/31/2016	1,199	60	N/A	261	N/A
9/30/2016	1,254	94	N/A	218	N/A
6/30/2016	1,185	112	N/A	223	N/A
3/31/2016	1,181	125	N/A	254	N/A
12/31/2015	1,162	308	N/A	80	N/A
9/30/2015	1,098	246	N/A	92	N/A
6/30/2015	995	193	N/A	-48	N/A
3/31/2015	945	203	N/A	-55	N/A
12/31/2014	947	15	N/A	23	N/A
9/30/2014	923	17	N/A	-4	N/A
6/30/2014	965	46	N/A	103	N/A
3/31/2014	995	67	N/A	124	N/A
12/31/2013	1,043	97	N/A	145	N/A
9/30/2013	1,043	106	N/A	175	N/A
6/30/2013	1,155	141	N/A	303	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 1762's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 1762's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 1762's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 1762's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 1762's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 1762's Return on Equity is forecast to be high in 3 years time

Chunghwa Chemical Synthesis & Biotech Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target increased by 12% to NT$91.50

Price target increased to NT$91.40

Price target decreased to NT$84.63

Price target increased to NT$103

Recent updates

Chunghwa Chemical Synthesis & Biotech Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings: EPS and revenues miss analyst expectations

Chunghwa Chemical Synthesis & Biotech Co., Ltd., Annual General Meeting, May 30, 2024

Insufficient new directors

New minor risk - Profit margin trend

Second quarter 2023 earnings: Revenues in line with analyst expectations

Upcoming dividend of NT$1.30 per share at 1.6% yield

Investor sentiment deteriorates as stock falls 16%

Now 26% undervalued after recent price drop

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces Cash Dividend for the Year 2022

Now 26% undervalued

Investor sentiment improves as stock rises 15%

Price target increased by 12% to NT$91.50

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to NT$91.40

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of NT$1.30 per share

Now 20% undervalued after recent price drop

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces Dividend, Payable on August 18, 2022

Price target decreased to NT$84.63

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces Appointment of Kuan Arthur¡G as Independent Director

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Investor sentiment improved over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Chunghwa Chemical Synthesis & Biotech Co., Ltd., Annual General Meeting, May 25, 2022

Price target increased to NT$103

Third quarter 2021 earnings released: EPS NT$1.09 (vs NT$0.44 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS NT$1.63 (vs NT$4.79 in 2Q 2020)

Upcoming dividend of NT$1.50 per share

First quarter 2021 earnings released: EPS NT$1.27 (vs NT$0.36 in 1Q 2020)

Full year 2020 earnings released: EPS NT$6.86 (vs NT$1.51 in FY 2019)

A Look At The Intrinsic Value Of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Chunghwa Chemical Synthesis & Biotech Co., Ltd., Annual General Meeting, May 24, 2021

Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TPE:1762) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

What To Know Before Buying Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762) For Its Dividend

New 90-day low: NT$59.10

Should You Rely On Chunghwa Chemical Synthesis & Biotech's (TPE:1762) Earnings Growth?

New 90-day low: NT$60.80

The Chunghwa Chemical Synthesis & Biotech (TPE:1762) Share Price Is Up 131% And Shareholders Are Boasting About It

Third quarter 2020 earnings released: EPS NT$0.44

Revenue and earnings miss expectations

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Announces the Change of Representative of the Company's Legal Person Director

New 90-day high: NT$75.30

New 90-day high - NT$66.50

First half earnings released

Upcoming Dividend of NT$0.80 Per Share

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies